Current Report Filing (8-k)
February 26 2020 - 4:38PM
Edgar (US Regulatory)
0000849399
false
0000849399
2020-02-24
2020-02-25
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of Earliest Event Reported): February 25, 2020
NortonLifeLock Inc.
(Exact
Name of Registrant as Specified in Charter)
Delaware
|
|
000-17781
|
|
77-0181864
|
(State
or Other Jurisdiction of
Incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
60
E. Rio Salado Parkway, Suite
1000, Tempe,
AZ
|
|
85281
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
Telephone Number, Including Area Code (650)
527-8000
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol
|
|
Name
of each exchange
on which registered
|
Common Stock, par value $0.01 per share
|
|
NLOK
|
|
The Nasdaq Stock Market LLC
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§
230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ¨
If an
emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
|
On
February 25, 2020, the Board of Directors (the “Board”) of NortonLifeLock Inc. (the “Company”) appointed
Eric K. Brandt to serve as a member of the Board and the Board’s Audit Committee.
Mr.
Brandt served as the Executive Vice President and Chief Financial Officer of Broadcom Corporation (“Broadcom”), a
global supplier of semiconductor devices, from February 2010 until February 2016, and he served as Broadcom’s Senior Vice
President and Chief Financial Officer from March 2007 until February 2010. From September 2005 until March 2007, Mr. Brandt served
as Chief Executive Officer & President, member of the Board of Avanir Pharmaceuticals, Inc. Beginning in 1999, he held various
positions at Allergan, Inc., a global specialty pharmaceutical company, including Executive Vice President of Finance and Technical
Operations and Chief Financial Officer. Prior to joining Allergan, Mr. Brandt spent ten years with The Boston Consulting Group,
a privately-held global business consulting firm, most recently serving as Vice President and Partner.
Mr.
Brandt serves as the Chairman of the Board of Directors of Dentsply Sirona Inc., a dental product solutions company, and as a
member of the Board of Directors of LAM Research Corporation, a semiconductor equipment company, and The Macerich Company, a real
estate investment trust. Mr. Brandt also currently serves as a member of the Georgia Tech President’s Advisory Board. Mr.
Brandt earned an M.B.A. degree from the Harvard Graduate School of Business and a B.S. degree in chemical engineering from the
Massachusetts Institute of Technology.
Mr.
Brandt will receive a pro-rated portion of the annual cash and equity retainer that is part of the standard compensation received
by the Company’s non-employee directors for service on the Board and its committees. In addition, Mr. Brandt will enter
into the Company’s standard form of indemnification agreement that was previously filed with the Securities and Exchange
Commission, which provides for indemnification of directors to the fullest extent allowed by Delaware law.
There
are no arrangements or understandings between Mr. Brandt and any other persons pursuant to which he was selected as a director.
Mr. Brandt has no family relationships with any of the Company’s directors or executive officers and he has no direct or
indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
A copy
of the Company’s press release announcing Mr. Brandt’s appointment to the Board is attached as Exhibit 99.01 to this
Current Report on Form 8-K.
Item
9.01
|
Financial
Statements and Exhibits.
|
(d)
Exhibits
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
NortonLifeLock Inc.
|
|
|
|
Date: February 26, 2020
|
By:
|
/s/ Bryan
Ko
|
|
|
Bryan Ko
|
|
|
General Counsel & Corporate
Secretary
|
Symantec (NASDAQ:SYMC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Symantec (NASDAQ:SYMC)
Historical Stock Chart
From Apr 2023 to Apr 2024